Prevalence and risk of progression of pancreatic cystic lesions in immunosuppressed patients: A systematic review and meta-analysis

doi:10.5500/wjt.v15.i2.98055

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=13

Jun 18, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Transplant. Jun 18, 2025; 15(2): 98055
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.98055

Prevalence and risk of progression of pancreatic cystic lesions in immunosuppressed patients: A systematic review and meta-analysis

Maximilian Kießler, Helmut Friess, Volker Assfalg

Maximilian Kießler, Volker Assfalg, Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, München 81675, Germany

Helmut Friess, Department of Surgery, Technische Universität München, München 81675, Germany

Author contributions: Kießler M performed the systematic review and meta-analysis and wrote the manuscript; Assfalg V had the idea for the study and supervised the data collection and analysis; Friess H supervised the study and made essential notes on the manuscript.

Conflict-of-interest statement: The authors declare no conflict-of-interest.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Maximilian Kießler, MD, Doctor, Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Straße 22, München 81675, Germany. maximilian.kiessler@tum.de

Received: June 16, 2024
Revised: November 10, 2024
Accepted: January 23, 2025
Published online: June 18, 2025
Processing time: 249 Days and 18.2 Hours

Core Tip

Core Tip: Immunosuppression does not increase the prevalence of pancreatic cystic lesions, nor does it increase the risk cyst progression in terms of size and development and resection criteria or worrisome features.